Arcturus Therapeutics In...
(ARCT)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | 157.75M | 205.75M | 12.36M | 9.54M | 20.79M | 15.75M | 13.00M | 20.38M | 6.14M | - | - | - | - |
Cost of Revenue | 2.96M | 143.05M | 171.86M | 55.95M | 32.44M | 16.98M | 410.00K | 294.00K | 51.00K | - | - | - | - |
Gross Profit | 154.79M | 62.70M | -159.50M | -46.41M | -11.65M | -1.23M | 12.59M | 20.09M | 6.09M | - | - | - | - |
Operating Income | -78.20M | 12.18M | -202.85M | -71.52M | -25.51M | -21.81M | -10.49M | -25.17M | -19.70M | -33.08M | -10.29M | -1.50M | -3.91M |
Interest Income | 17.36M | 2.58M | 753.00K | 470.00K | 408.00K | 514.00K | 89.00K | 798.00K | 338.00K | 239.00K | 22.00K | 2.00K | 21.00K |
Pretax Income | -27.89M | 10.64M | -203.67M | -72.15M | -25.99M | -21.79M | -10.90M | -24.53M | -19.40M | -32.85M | -10.49M | -1.58M | -3.93M |
Net Income | -29.73M | 9.35M | -206.86M | -71.36M | -25.72M | -21.79M | -10.90M | -24.60M | -19.45M | -32.83M | -10.55M | -1.58M | -3.93M |
Selling & General & Admin | 52.87M | 46.07M | 41.45M | 23.22M | 12.66M | 20.58M | 7.57M | 5.36M | 4.99M | 5.84M | 3.22M | 683.00K | 2.08M |
Research & Development | 192.13M | 147.75M | 173.76M | 57.85M | 33.64M | 16.98M | 15.92M | 18.39M | 13.46M | 25.11M | 7.07M | 818.00K | 1.82M |
Other Expenses | - | -244.00K | - | - | - | - | -348.00K | 1.42M | 1.25M | 2.13M | - | - | - |
Operating Expenses | 235.95M | 193.58M | 215.21M | 81.06M | 46.30M | 37.56M | 23.49M | 25.17M | 19.70M | 33.08M | 10.29M | 1.50M | 3.91M |
Interest Expense | 767.00K | 420.00K | 2.67M | 361.00K | 446.00K | 186.00K | 150.00K | 295.00K | 251.00K | 2.00K | 197.00K | 80.00K | 44.00K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 245.00M | 193.58M | 215.21M | 81.06M | 46.30M | 37.56M | 23.49M | 25.17M | 19.70M | 33.08M | 10.29M | 1.50M | 3.91M |
Income Tax | 1.83M | 1.29M | 3.19M | -784.00K | -270.00K | 212.00K | 1K | 73.00K | 51.00K | -17.00K | 61.00K | 65.00K | 21.00K |
Shares Outstanding (Basic) | 26.63M | 26.45M | 26.32M | 20.30M | 12.07M | 10.07M | 3.09M | 3.94M | 3.09M | 1.95M | 1.45M | 1.59M | 1.59M |
Shares Outstanding (Diluted) | 26.63M | 27.09M | 26.32M | 20.30M | 12.07M | 10.07M | 3.09M | 3.94M | 3.09M | 1.95M | 1.45M | 1.59M | 1.59M |
EPS (Basic) | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
EPS (Diluted) | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 | -3.53 | -6.25 | -6.29 | -16.81 | -7.25 | -0.99 | -2.47 |
EBITDA | -24.17M | 13.70M | -201.66M | -70.64M | -24.42M | -20.71M | -10.34M | -947.00K | -1.72M | -32.81M | -10.28M | -1.51M | -3.92M |
Depreciation & Amortization | 2.96M | 1.53M | 1.19M | 882.00K | 684.00K | 582.00K | 410.00K | 294.00K | 51.00K | 31.00K | 8.00K | 7.00K | 6.00K |